365 related articles for article (PubMed ID: 9007114)
41. Preliminary results of a phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
Sørensen JB; Wedervang K; Dombernowsky P
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-18-S12-20. PubMed ID: 9331114
[TBL] [Abstract][Full Text] [Related]
42. Treatment of patients with upper gastrointestinal carcinomas.
Ajani JA
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
[TBL] [Abstract][Full Text] [Related]
43. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
Ajani JA; Ilson DH; Kelsen DP
Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
[TBL] [Abstract][Full Text] [Related]
44. Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma.
Tas F; Derin D; Guney N; Camlica H; Aydiner A; Topuz E
Lung Cancer; 2007 Jul; 57(1):79-83. PubMed ID: 17383768
[TBL] [Abstract][Full Text] [Related]
45. Chemotherapy for relapsed head and neck cancer: paclitaxel, cisplatin, and 5-fluorouracil in chemotherapy-naive patients. A dose-finding study.
Benasso M; Numico G; Rosso R; Merlano M; Ricci I; Gentile A
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-46-S19-50. PubMed ID: 9427266
[TBL] [Abstract][Full Text] [Related]
46. Phase I/II trial of weekly paclitaxel in patients with advanced lung cancer.
Akerley W
Semin Oncol; 1996 Dec; 23(6 Suppl 16):55-8. PubMed ID: 9007123
[TBL] [Abstract][Full Text] [Related]
47. Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience.
Catimel G; Spielmann M; Dieras V; Tubiana-Hulin M; Bonneterre J; Pouillart P; Kayitalire L; Guastalla JP; Graffand N; Garet F; Dumortier A; Pellae-Cosset B
Semin Oncol; 1997 Feb; 24(1 Suppl 3):S8-12. PubMed ID: 9071333
[TBL] [Abstract][Full Text] [Related]
48. Paclitaxel and simultaneous radiation in locally advanced stage IIIA/B non-small cell lung cancer: a clinical phase I study.
Vogt HG; Kolotas C; Martin T; Schneider LV; Goes-Schmieder R; Mitrou PS; Diergarten K; Kober B; Zamboglou N
Semin Oncol; 1996 Dec; 23(6 Suppl 16):120-3. PubMed ID: 9007138
[TBL] [Abstract][Full Text] [Related]
49. Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
Jett JR; Hatfield AK; Hillman S; Bauman MD; Mailliard JA; Kugler JW; Morton RF; Marks RS; Levitt R
Cancer; 2003 May; 97(10):2498-503. PubMed ID: 12733149
[TBL] [Abstract][Full Text] [Related]
50. Update: the M.D. Anderson Cancer Center experience with paclitaxel in the management of breast carcinoma.
Holmes FA
Semin Oncol; 1995 Aug; 22(4 Suppl 8):9-15. PubMed ID: 7543702
[TBL] [Abstract][Full Text] [Related]
51. Preliminary results of a phase I/II clinical trial of paclitaxel and carboplatin in non-small cell lung cancer.
Natale RB
Semin Oncol; 1996 Dec; 23(6 Suppl 16):51-4. PubMed ID: 9007122
[TBL] [Abstract][Full Text] [Related]
52. Dose-finding study of paclitaxel (Taxol) plus cisplatin in patients with non-small cell lung cancer.
Klastersky J; Sculier JP
Semin Oncol; 1994 Oct; 21(5 Suppl 8):39-43. PubMed ID: 7939762
[TBL] [Abstract][Full Text] [Related]
53. Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
Kakolyris S; Agelidou A; Androulakis N; Tsaroucha E; Kouroussis Ch; Agelidou M; Karvounis N; Veslemes M; Christophylakis Ch; Argyraki A; Geroyianni A; Georgoulias V
Lung Cancer; 2006 Jul; 53(1):59-65. PubMed ID: 16716447
[TBL] [Abstract][Full Text] [Related]
54. Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.
du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Warm M; Bauknecht T; Schröder W; Olbricht S; Nitz U; Jackisch C
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-44-S15-52. PubMed ID: 9346222
[TBL] [Abstract][Full Text] [Related]
55. Biweekly paclitaxel and cisplatin: a phase I/II study in the first-line treatment of metastatic breast cancer.
O'Reilly SE; Gelmon KA
Semin Oncol; 1995 Jun; 22(3 Suppl 6):109-11. PubMed ID: 7597426
[TBL] [Abstract][Full Text] [Related]
56. Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trial.
Gatzemeier U; Heckmayer M; Neuhauss R; Schlüter I; von Pawel J; Wagner H; Dreps A
Semin Oncol; 1995 Dec; 22(6 Suppl 15):24-8. PubMed ID: 8643966
[TBL] [Abstract][Full Text] [Related]
57. Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer.
Tung N; Berkowitz R; Matulonis U; Quartulli M; Seiden M; Kim Y; Niloff J; Cannistra SA
Gynecol Oncol; 2000 May; 77(2):271-7. PubMed ID: 10785477
[TBL] [Abstract][Full Text] [Related]
58. A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer.
Birch R; Weaver CH; Hainsworth JD; Bobo C; Greco FA
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-135-S12-137. PubMed ID: 9331138
[TBL] [Abstract][Full Text] [Related]
59. Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trials.
DeVore RF; Jagasia M; Johnson DH
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-27-S12-29. PubMed ID: 9331116
[TBL] [Abstract][Full Text] [Related]
60. Interim results of a phase I/II study of biweekly paclitaxel and cisplatin in patients with metastatic breast cancer.
Tolcher AW; Gelmon KA
Semin Oncol; 1995 Aug; 22(4 Suppl 8):28-32. PubMed ID: 7638639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
